News Gilead, Arcus say TIGIT combo encouraging in GI cancer Gilead and Arcus’ efforts to rebuild confidence in TIGIT as a drug target for cancer immunotherapies have shuffled forwards again, with new data showing signs of efficacy
Events Partner Content FREE - Gastrointestinal Cancer Drug Development Digital Summ... FREE - Gastrointestinal Cancer Drug Development Summit
News MSD ordered to pull injectable Keytruda from sale in Europe MSD has been rocked by a court judgment ordering it to stop making and selling subcutaneous Keytruda in eight European markets.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
